CELZ vs PSA · rev $11.0K vs rev $4.82B
Creative Medical Technology Holdings Inc (CELZ) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Creative Medical Technology Holdings Inc (CELZ) is a biotechnology company listed on NASDAQ.
PSA (PSA) common stock.
Latest reported CELZ revenue for 2024-12-31 was $11.0K. Net income was -$5.5M. Revenue was up 22.2% from 2023-12-31 to 2024-12-31. CELZ currently screens at market cap $8.3M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CELZ currently screens at market cap $8.3M. PSA currently screens at market cap $0.
Not investment advice. Open the CELZ and PSA stock pages for the full models.
Not investment advice.